Gossamer Bio (GOSS) Total Liabilities: 2022-2025
Historic Total Liabilities for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $291.2 million.
- Gossamer Bio's Total Liabilities fell 1.88% to $291.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $291.2 million, marking a year-over-year decrease of 1.88%. This contributed to the annual value of $285.8 million for FY2024, which is 14.71% up from last year.
- Gossamer Bio's Total Liabilities amounted to $291.2 million in Q3 2025, which was up 1.44% from $287.0 million recorded in Q2 2025.
- Gossamer Bio's 5-year Total Liabilities high stood at $296.7 million for Q3 2024, and its period low was $232.6 million during Q1 2024.
- Its 3-year average for Total Liabilities is $268.9 million, with a median of $285.8 million in 2024.
- In the last 5 years, Gossamer Bio's Total Liabilities decreased by 8.94% in 2023 and then increased by 23.30% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's Total Liabilities stood at $260.4 million in 2022, then declined by 4.31% to $249.1 million in 2023, then increased by 14.71% to $285.8 million in 2024, then dropped by 1.88% to $291.2 million in 2025.
- Its Total Liabilities stands at $291.2 million for Q3 2025, versus $287.0 million for Q2 2025 and $286.8 million for Q1 2025.